Jiangsu Nanfang Medical Co., Ltd.

SSE:603880.SS

6.3 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 170.922147.553153.192160.652137.547129.786117.441126.737226.131152.281137.376112.67143.043122.187142.883120.688141.682161.852181.454628.658100.435140.006128.456122.715100.511129.453119.578111.673119.12128.275120.242134.45105.743112.302108.203111.865111.865
Cost of Revenue 156.249218.147141.046140.418121.78146.156100.82798.056199.39145.512120.07592.942114.65299.716115.87594.713107.884102.728140.065391.09375.255115.6698.26993.76678.008105.71588.3984.55188.61497.67587.96396.25477.66980.40577.21195.91495.914
Gross Profit 14.673-70.59412.14620.23415.766-16.3716.61428.68126.7416.76917.30119.72828.39122.47227.00825.97533.79859.12441.389237.56525.18124.34630.18728.94922.50323.73731.18727.12230.50730.59932.27938.19628.07431.89830.99215.95115.951
Gross Profit Ratio 0.086-0.4780.0790.1260.115-0.1260.1410.2260.1180.0440.1260.1750.1980.1840.1890.2150.2390.3650.2280.3780.2510.1740.2350.2360.2240.1830.2610.2430.2560.2390.2680.2840.2650.2840.2860.1430.143
Reseach & Development Expenses 6.1775.8778.1267.9576.6537.7855.586.5028.3145.3917.4867.5787.2717.88.9116.3347.57813.6449.3267.2833.715.5775.666.4124.6515.436.6584.5093.4934.8695.5459.498018.822000
General & Administrative Expenses 11.92511.29233.647-5.73810.823-21.72232.809-5.83512.758-16.56127.274-4.1739.429-13.29425.6891.72115.181-12.85611.069-0.5928.05-9.7359.137-2.2825.995-6.5578.639-5.82110.341-25.38513.19211.39911.601-23.99413.33500
Selling & Marketing Expenses 0.8293.1882.6340.6591.7473.8271.3430.7341.8242.2432.5971.1341.2164.3981.6521.6371.476-19.262.367131.0562.2893.2643.2462.8862.4813.0025.2452.9682.4526.6942.6571.9411.9012.7161.64200
SG&A 12.75314.4836.2817.15812.272-17.89534.152-5.10114.582-14.31829.871-3.03810.645-8.89627.3413.35816.657-32.11513.436130.46410.339-6.47212.3830.6048.476-3.55513.884-2.85212.793-18.69115.84913.34113.502-21.27814.97800
Other Expenses 3.76597.438-18.391-2.0212.986-1.546-0.181-0.1551.25734.266-13.73915.2160.685-1.43-0.004-1.177-0.0018.454-0.1-0.001-0.152.560.0530.0180.018-0.824-0.0460.116-0.005-1.7591.21-0.4150.3760.3810.97600
Operating Expenses 22.696117.79426.01617.13615.93924.22919.71324.04524.15225.33923.61819.75618.60132.40225.20822.21924.94910.09127.854152.84414.65219.63719.20716.74213.53822.73821.7616.0612.98322.67316.89714.49914.56418.75615.9430.0090.009
Operating Income -8.023-188.388-14.6683.097-0.173-154.367-1.2280.8547.92-36.809-4.9731.5597.44-47.2845.5114.8348.866-0.7637.99684.02810.422-11.32410.57515.42210.73-13.7614.58730.80613.694.47113.16219.39312.68716.2512.49315.95115.951
Operating Income Ratio -0.047-1.277-0.0960.019-0.001-1.189-0.010.0070.035-0.242-0.0360.0140.052-0.3870.0390.040.063-0.0050.0440.1340.104-0.0810.0820.1260.107-0.1060.1220.2760.1150.0350.1090.1440.120.1450.1150.1430.143
Total Other Income Expenses Net 0.003-0.381-2.328-3.4742.083-1.5460-0.1550.0030.145-0.1-2.2310-1.43-0.004-1.177-0.0018.454-0.1-0.001-0.152.560.0530.0180.018-0.824-0.0460.116-0.005-1.7450.2110.1160.3760.1890.976-0.009-0.009
Income Before Tax -8.019-188.769-16.996-2.252-0.076-155.913-1.2280.6997.923-36.663-0.4490.3287.44-48.7145.5063.6568.8667.6927.89684.02710.271-8.76510.62715.4410.748-14.58314.54130.92213.6852.72514.37119.5113.06216.43913.46915.94215.942
Income Before Tax Ratio -0.047-1.279-0.111-0.014-0.001-1.201-0.010.0060.035-0.241-0.0030.0030.052-0.3990.0390.030.0630.0480.0440.1340.102-0.0630.0830.1260.107-0.1130.1220.2770.1150.0210.120.1450.1240.1460.1240.1430.143
Income Tax Expense -0.134-11.1560.1820.4520.158-1.194-0.698-0.351.012-14.077-1.2590.0920.838-11.1572.0821.542-0.1152.039-1.2579.8390.982-1.691.1072.151.333-0.1981.5874.7371.632-2.9171.3963.2921.4721.4022.4672.9432.943
Net Income -7.918-177.356-14.34-0.7191.745-154.68-0.6380.976.931-22.5860.9020.2366.727-37.5013.5222.0889.1286.1738.67973.7839.433-5.15910.13113.7779.302-13.25514.05926.24112.2046.48413.29116.24711.5815.00310.94913.01413.014
Net Income Ratio -0.046-1.202-0.094-0.0040.013-1.192-0.0050.0080.031-0.1480.0070.0020.047-0.3070.0250.0170.0640.0380.0480.1170.094-0.0370.0790.1120.093-0.1020.1180.2350.1020.0510.1110.1210.110.1340.1010.1160.116
EPS -0.027-0.609-0.05-0.0030.006-0.54-0.0020.0030.024-0.0780.0030.0010.023-0.150.0120.0070.0310.0210.0290.260.032-0.0180.0330.0470.033-0.0450.0470.090.0550.0270.0770.0740.0530.0720.0530.0610.061
EPS Diluted -0.027-0.609-0.05-0.0030.006-0.54-0.0020.0030.024-0.0780.0030.0010.023-0.150.0120.0070.0310.0210.0290.260.032-0.0180.0330.0470.033-0.0430.0470.090.0550.0270.0770.0740.0530.0720.0530.0610.061
EBITDA -2.307-170.381-12.54217.26814.844-128.02412.71117.88421.097-18.6162.23811.11120.353-35.4114.14710.34915.6339.9589.85489.33216.202-2.45713.71719.25712.695.8121.7517.18716.2496.86916.078226.68313.50916.37815.91717.41917.419
EBITDA Ratio -0.013-1.155-0.0820.1070.108-0.9860.1080.1410.093-0.1220.0160.0990.142-0.290.0990.0860.110.0620.0540.1420.161-0.0180.1070.1570.1260.0450.1820.1540.1360.0540.1341.6860.1280.1460.1470.1560.156